Back
Snap, Inc. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Sell
50
SNAP
Snap, Inc.
Last Price:
$7.57
Seasonality Move:
1.76%
Sell
18
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$33.50
Seasonality Move:
-0.96%
Sell
50
Snap, Inc. (SNAP)
is a Sell
Is Snap, Inc. a Buy, Sell or Hold?
-
The current Snap, Inc. [SNAP] share price is $7.63. The Score for SNAP is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
SNAP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $32.84. The Score for RARE is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
SNAP Stock Price Chart
What is Snap, Inc.'s stock price today?
-
The Snap, Inc. share price today is $7.63Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNAP is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $32.84Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.
SNAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.07 | Buy |
| Relative Strength Index (14 RSI): | 46.89 | Sell |
| Chaikin Money Flow: | -12184172 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.67 | Buy |
| Relative Strength Index (14 RSI): | 41.45 | Sell |
| Chaikin Money Flow: | -1089594 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
SNAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.57 | Buy |
| 20-day SMA: | 7.66 | Sell |
| 50-day SMA: | 7.87 | Sell |
| 200-day SMA: | 8.26 | Sell |
| 8-day EMA: | 2.99 | Buy |
| 20-day EMA: | 1.37 | Buy |
| 50-day EMA: | 0.58 | Buy |
| 200-day EMA: | 0.15 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.17 | Sell |
| 20-day SMA: | 34.68 | Sell |
| 50-day SMA: | 33.7 | Sell |
| 200-day SMA: | 33.61 | Sell |
| 8-day EMA: | 13.04 | Buy |
| 20-day EMA: | 5.99 | Buy |
| 50-day EMA: | 2.54 | Buy |
| 200-day EMA: | 0.65 | Buy |
Snap, Inc. Earnings Growth & SNAP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.15 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
Snap, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||